Abstract Parathyroid hormone (PTH) is a principal regulator of calcium homeostasis. Previously, we studied single-nucleotide polymorphisms present in the major genes in the PTH pathway (PTH, PTHrP, PTHR1, PTHR2) in relation to bone mineral density (BMD) and fracture incidence. We found that haplotypes of the PTH gene were associated with fracture risk independent of BMD. In the present study, we evaluated the relationship between PTH haplotypes and femoral neck bone size. Hip structure analysis and BMD of the femoral neck was assessed by DXA in elderly women from the Malmö Osteoporosis Prospective Risk Assessment study. Data on hip fracture, sustained as a result of low trauma, after the age of 45 years were also analyzed. Haplotypes derived from six polymorphisms in the PTH locus were analyzed in 750 women. Carriers of haplotype 9 had lower values for hip geometry parameters cross-sectional moment of inertia (P = 0.029), femoral neck width (P = 0.049), and section modulous (P = 0.06), suggestive of increased fracture risk at the hip. However, this did not translate into an increased incidence of hip fracture in the studied population. Women who suffered a hip fracture compared to those who had not had longer hip axis length (HAL) (P \ 0.001). HAL was not significantly different among haplotypes. Polymorphisms in the PTH gene are associated with differences in aspects of femoral neck geometry in elderly women; however, the major predictor of hip fracture in our population was HAL, to which PTH gene variation does not contribute significantly.
Abstract Parathyroid hormone (PTH) is a principal regulator of calcium homeostasis. Previously, we studied single-nucleotide polymorphisms present in the major genes in the PTH pathway (PTH, PTHrP, PTHR1, PTHR2) in relation to bone mineral density (BMD) and fracture incidence. We found that haplotypes of the PTH gene were associated with fracture risk independent of BMD. In the present study, we evaluated the relationship between PTH haplotypes and femoral neck bone size. Hip structure analysis and BMD of the femoral neck was assessed by DXA in elderly women from the Malmö Osteoporosis Prospective Risk Assessment study. Data on hip fracture, sustained as a result of low trauma, after the age of 45 years were also analyzed. Haplotypes derived from six polymorphisms in the PTH locus were analyzed in 750 women. Carriers of haplotype 9 had lower values for hip geometry parameters cross-sectional moment of inertia (P = 0.029), femoral neck width (P = 0.049), and section modulous (P = 0.06), suggestive of increased fracture risk at the hip. However, this did not translate into an increased incidence of hip fracture in the studied population. Women who suffered a hip fracture compared to those who had not had longer hip axis length (HAL) (P \ 0.001). HAL was not significantly different among haplotypes. Polymorphisms in the PTH gene are associated with differences in aspects of femoral neck geometry in elderly women; however, the major predictor of hip fracture in our population was HAL, to which PTH gene variation does not contribute significantly.
Keywords Bone architecture/structure Á Bone density technology Á Ultrasound Á Osteoporosis Á Fracture Á PTH Á PTHrP Osteoporosis is a common skeletal disease characterized by low bone mineral density (BMD) and microarchitectural deterioration of bone tissue. The ultimate outcome of osteoporosis is fracture, the most serious type being hip fracture in terms of morbidity, mortality, and economic costs [1, 2] .
Bone strength is influenced by bone mass and bone quality, which encompasses both structural and biomechanical aspects. Bone strength is determined by a combination of genetic and environmental factors. Family and twin studies have shown a significant heritable component, accountable for up to 80% of both BMD and femoral structure [3, 4] , 51-79% of hip axis length (HAL) [5] , and 60-80% of the other aspects of bone geometry as well as bone quality [3, 6, 7] . Data modeled in twins indicate that both specific and shared genetic factors act on individual bone phenotypes [8, 9] and may explain the partially BMD-independent associations often observed with fracture [10, 11] .
Parathyroid hormone (PTH) is a key regulator of calcium metabolism, maintaining levels of calcium ion in serum by modulating osteoclastic bone resorption and calcium reabsorption in the kidneys [12] . PTH secretion is induced by low serum calcium levels, resulting in the activation of osteoclasts. In the case of hyperparathyroidism, a continuously elevated PTH level may lead to osteoporosis and fracture. However, PTH has a dual action; and when elevation is intermittent, PTH promotes bone formation. Consequently, when administered intermittently through stimulation of osteoblast proliferation and differentiation, PTH has been proven to be a useful bone anabolic agent [12] [13] [14] . Associated with PTH treatment are beneficial microarchitectural changes affecting trabecular width, connectivity, and structure, leading to increased bone strength, particularly in the vertebrae [15, 16] . However, a differential effect on cortical bone has also been noted, with initially decreasing BMD values at the hip and distal forearm [13, 17, 18] . Another protein in the PTH pathway, the PTH-related peptide (PTHrP), has been shown to be important for skeletal development during early bone growth and as a para-malignant phenomenon [19, 20] .
Previously, we studied several genes within the PTH complex (PTH, PTHrP, PTHR1, and PTHR2) in a cohort of elderly Swedish women and reported an association between haplotypes of PTH and fracture, while no such association was found for the other genes in the pathway [21] . The relationship with fracture was independent of an effect on bone mass.
Given the evidence for the effects of PTH on bone size and the fact that bone size itself is an independent risk factor for fracture, the aim of this study was to investigate whether the single-nucleotide polymorphisms (SNPs) within PTH play a role in the regulation of femoral neck geometry and bone quality in elderly women. Additionally, within this cohort, whose age confers a high risk of fracture, we evaluated the contribution to hip fracture risk.
Materials and Methods

Subjects
The study cohort comprised the Malmö Osteoporosis Prospective Risk Assessment (OPRA) study of 1,604 women aged 75 years at invitation, which has been previously described in detail [22] . Briefly, these women were randomly selected from the city files in Malmö between December 1995 and May 1999. There were 1,044 (65%) subjects who accepted baseline investigation, and no exclusion criteria were used. The vast majority were self-ambulatory [23] and of Caucasian origin [22] . At baseline, BMD was assessed and blood samples were collected for DNA analysis and determination of serum PTH concentration. The participants also answered a questionnaire regarding general health, medication, and previous falls and fractures. The Ethics Committee of Lund University approved the study.
Fracture
At the baseline visit, data on self-reported fractures sustained between the ages of 20 and 75 years were collected by questionnaire and verified from radiological files as previously reported [24] . Prospective fracture data were also collected and similarly verified [25] . The mean prospective follow-up time was 7.0 years (range 5.4-9.0). In this study, we report only on hip fractures.
BMD and Hip Structure Analysis
All image files were reanalyzed by a single operator, who was blinded for fracture status, using hip strength analysis software provided by Lunar Instruments (Madison, WI). The X-ray absorption data of the proximal femur are, with this software, extracted from the output image data file, and the amount of bone mineral and its distribution within the femoral neck are calculated. The reproducibility of the hip strength analysis was determined by five repeated scans in six young healthy subjects after repositioning of the subject. The standard error of the mean (SEM) and the coefficient of variation (CV) of BMD and the hip strength indices were calculated. On average, the SEM of hip strength measurements was 0.02-0.06 and the CV was 0.6-3.7%.
Cross-sectional moment of inertia (CSMI) is an estimate of the ability of the femoral neck to withstand bending forces and was calculated using the mass distribution of the absorption curve [26] . The CSMI estimated with dualenergy X-ray absorptiometry (DXA) has been highly correlated with the CSMI measured directly on cadaver specimens (r 2 = 0.96) [26] . The automatic identification of the weakest cross section of the femoral neck is the central part of the hip strength analysis software, and this crosssection level is then used for the subsequent calculations of section modulus (SM, cm 3 ) and femoral neck width (FN width, cm). SM is also an estimate of the ability of the FN to withstand bending forces and is calculated as CSMI divided by the distance from the center of the mass to the superior neck margin. The hip axis length (HAL, cm) is defined as the linear distance from the pelvic rim to the lateral aspect of the femur along the FN axis defined in the hip strength analysis and measured using the DXA ruler option.
Quantitative Ultrasound
Ultrasound measurements, speed of sound (SOS), broadband ultrasound attenuation (BUA), and stiffness index (SI), a derivative of BUA and SOS, were performed using a Lunar AchillesÒ system. The right calcaneus was measured unless there was a history of previous injury or fracture on the right side. Precision of ultrasound in our hands was 1.5% [27] . The long-term stability of the apparatus was checked by daily calibrations.
DNA Genotyping
Genotyping of the PTH gene as described in detail previously was performed using Taqman allelic discrimination assay (Applied Biosystems, Foster City, CA) [21] . All polymorphisms were amplified according to standard conditions (50°C for 2 min, 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C). After PCR amplification, genotypes were determined using an ABI Prism 7900HT sequence detector (Applied Biosystems). In this report we present data on 750 women for whom complete genotype data for all six PTH polymorphisms were available.
PTH Polymorphisms and Haplotypes
We studied six SNPs in and around the region of the PTH gene (11p15.3-p15.1). These SNPs were selected from Ensembl (www.ensembl.org) representing the most commonly occurring haplotypes according to Haploview (www.broadinstitute.org/haploview/haploview). The polymorphisms selected were rs307253 located *4 kb downstream, rs307247 located *100 bp downstream, rs6254 in intron 2 (also known by its restriction enzyme recognition site BstBI), rs1459015 located *5 kb upstream, rs10500783 located *56 kb upstream, and rs10500784 located 56.2 kb upstream.
As previously reported, five common haplotypes defined by the six SNPs in LD were identified, reported in the order [28] . Haplotype analyses were performed according to whether individuals possessed 0, 1, or 2 copies of the haplotype allele. Associations between genotypes and bone variables were made using GLM ANOVA correcting, as appropriate, for confounding factors. Spearman's correlation was used to identify relationships between clinical measurements, bone geometry, as well as quality parameters. Significance was set at P \ 0.05, and the P values reported are nominal without correction for multiple testing.
Results
Subject Characteristics
The clinical characteristics of the OPRA study participants including BMD, ultrasound, and FN geometry measurements are shown in Table 2 . In brief, all women were 75 years old (range 75.01-75.98) and only 14% were current smokers. Serum PTH levels were normally distributed for age, and no exclusions were made. The PTH genotype distribution was in HWE, and the five common haplotypes, which accounted for [ 98% of alleles at the PTH locus, are reported in Table 1 .
Relationship Between FN Geometry and Anthropometric Variables
Correlations between FN geometry, BMD, height, and weight were evaluated. Significant positive correlations were observed between all variables (P \ 0.01). Current weight correlated more strongly with FN width (R = 0.43, P \ 0.001), CSMI (R = 0.51, P \ 0.001), and SM (R = 0.50, P \ 0.001) than did current height (Table 3) .
FN Geometry, Bone Quality, and Hip Fracture
We compared women who had suffered a hip fracture during their lifetime (n = 117/750, includes retrospective and prospective fractures) against those who had not (n = 633/750) ( Table 4 ). Weight and current height were not significantly different between the two groups, although women who suffered a hip fracture were significantly taller at age 20 (P \ 0.001). HAL was greater while SM was lower, as was BMD in the women with hip fractures (P \ 0.01); but there were no significant differences in either FN width or CSMI. Of those women who had sustained a hip fracture, three suffered the fracture between the ages of 45 and 54 years; and excluding them from the analysis did not appreciably alter the results. All ultrasound measures at the calcaneus were lower in the hip fracture women.
Haplotype Associations with FN Geometry and Ultrasound
Measures of FN geometry in relation to PTH haplotype are reported in Table 5 . We observed modest associations between haplotype 9 and FN width (P = 0.029) and CSMI (P = 0.049) and trends toward association for SM (P = 0.063) after correction for current height and weight. No association was observed with HAL (P = 0.78). Individuals with two copies of haplotype 9 had the lowest values and the relationship was dose-dependent. Comparison of those with one or more copies against zero copies of the haplotype increased the significance of these associations (P = 0.008, 0.018, and 0.029 for FN width, CSMI, and SM, respectively). Although haplotype 5 was associated with current height (P = 0.038), no significant association between FN geometry and the other PTH haplotypes was observed. Individually, PTH polymorphisms were not associated with FN geometry, with the exception of rs1459015, which was associated with FN width (34.4 vs. 33.9 vs. 32.8, P = 0.046).
We found no association between PTH haplotypes or individual genotypes and measures of BUA, SOS, or SI (Table 5) . However, for all the haplotypes studied, all values were lowest in those carrying two copies of the haplotype.
Haplotype Associations with Hip Fracture
A hip fracture was sustained by 117 women, and all of these were the result of low-energy trauma and occurred after the age of 45. Individuals carrying one or more copies of haplotype 9 were found to be underrepresented among those who had sustained a hip fracture compared to those who had not fractured (v 2 = 4.1, P = 0.043). No differences in distribution were observed for the other haplotypes analyzed.
Compared to the population as a whole, among the women who had sustained a hip fracture, measures of FN geometry were not significantly different between individuals who carried or did not carry haplotype 9 (Table 6) .
Discussion
In addition to BMD, other bone phenotypes also have a strong genetic component; and several genes, like RANKL, eNOS, TNFa, WNT10b, FZD1, IGF-1, ESR1, and ESR2, have been associated with aspects of FN geometry or indices of bone strength [29] [30] [31] [32] [33] [34] [35] . PTH is an important modulator of skeletal regulation, and we have shown recently that genetic variation within the PTH locus is associated with fracture through mechanisms/pathways independent of BMD [21] . Furthermore, another study suggests a possible effect of PTH polymorphisms on bone dimensions in middle-aged 
Values are means (SD) adjusted for height, body weight, FN geometry, BMI, smoking, and FN BMD (ultrasound) women [36] . In light of these observations, we evaluated variation in the PTH locus in relation to measures of bone quality and FN bone geometry in elderly Swedish women at risk of fracture. Age and BMD are the major contributing factors for fracture risk, but a number of other risk factors also need to be taken into account. Bone strength is a complex trait that is not captured by BMD alone, and both macro-and microstructural components play an important role. One facet of this structural component is hip geometry, which has been implicated as an independent risk factor for fracture [37, 38] .
Hip structure analysis (HSA) allows the extraction of geometric bone strength information from hip DXA scans [39] . The analysis relies on three main variables: hip axis length, FN diameter, and distribution of bone mass, from which a number of other indices are derived. We analyzed variables shown to be most relevant to fracture in other studies. In a large Australian study, smaller FN diameter and CSMI were found to be independent risk factors for hip fracture [37] . Another study in Caucasian and South American women found that HAL and femur strength index were, alongside BMD, independent predictors of hip fracture [38] .
In our study, we report that PTH haplotype 9 displays lower values for all measures of FN geometry, although it is significantly associated only with FN width, CSMI, and SM. Despite these findings that might suggest a higher susceptibility to hip fracture, through reduced mechanical strength individuals carrying this haplotype were not overrepresented among those who had suffered a hip fracture. This is in keeping with our previous observation of a slight protective effect of this haplotype on fracture overall. We also reported previously that PTH haplotypes 1 and 5 were at slightly increased risk of fracture overall; however, this does not appear to extend to fractures sustained at the hip. Furthermore, these haplotypes do not appear to make a significant contribution to bone dimensions at this site.
The literature relating to FN width and its relationship with hip fracture is conflicting, with both increased and decreased widths reported among fracture patients, mirroring the fact that mechanical strength is dependent on both size and distribution of bone mass [40, 41] . In our cohort of elderly women, HAL was significantly longer in women with a hip fracture and the bending strength index (section modulus) was lower, yet FN width and CSMI were similar in the fracture and nonfracture groups. This may be explained by counteractions between FN diameter and thinning of the cortices in hip fracture patients [42] ; alternatively, FN diameter may be dichotomously distributed in hip fracture patients.
Only a limited number of studies have examined PTH gene variations and bone phenotypes, and only two other studies have examined bone size. Gong et al. [36] reported a significant association between PTH genotype and radiogrammetric bone dimensions; however, analyses were restricted to the hand, i.e., cross-sectional cortical area of the metacarpal and annual rate of change in radial cortical area. In contrast, Lei et al. [43] found no association with bone size at the lumbar spine and hip. These results are suggestive of skeletal site-specific genetic effects of PTH on bone size.
The anabolic effect of PTH is exploited as a treatment for osteoporosis, contributing both to aspects of bone strength and BMD. Animal studies indicate that changes in iliac crest bone biopsies after PTH treatment correlate with microstructure in both the femoral neck and vertebrae [15] . In a prospective, randomized, multicenter study, teriparatide has been shown to positively influence HSA parameters such as section modulus and cross-sectional area [44] . There is no effect, however, on HAL since this is determined by the end of adolescence and is unchanged with age, whereas the circumference of the femoral neck and cortical thickness increase with age and vary in response to the magnitude of biomechanical loading. This is in keeping with our observed association that haplotypes of PTH affect only those aspects of FN geometry (FN diameter, CSMI, and SM) which can be altered, suggesting that variation in the PTH gene may affect bone geometry throughout life. However, since not all patients respond to PTH treatment, it is likely that there is a complex mechanism involving other genetic and environmental factors in the response to PTH.
Our study is of interest since it is the only one to evaluate PTH genotype in relation to FN geometry and hip fracture in an age-relevant cohort of elderly women whose age confers a high risk of fracture. The proportion with hip fracture is relatively high at 16% in the cohort, although it may still be considered low in the context of genotype distribution. However, the study population is large and ethnically homogenous, and the narrow age band eliminates age-associated confounding factors. Other strengths include the comprehensive selection of SNPs encompassing the PTH locus, capturing genetic variation in both the 5 0 and 3 0 regions, thus ensuring capture of as much as possible of the genetic variation across the region of the gene. Since none of the SNPs included in our study has a known function, we must assume LD with other functional polymorphisms within or close to the gene. A mutation at an intron-exon donor splice site, resulting in loss of the signal peptide encoding exon 2, has been described in familial hypoparathyroidism [45] , while mutations in the 3' UTR may affect mRNA stability [46] . The genes in the immediate vicinity of PTH have not been implicated in bone metabolism, but interactions between polymorphisms in other calcium regulatory pathway genes, e.g., calcium-sensing receptor (CaSR), Klotho and fibroblast growth factor-23 (FGF23), should be considered and further explored.
There are a few potential limitations to our study. Although HSA of FN geometry has been shown to be prognostic of hip fracture [47] , quantitative CT measurements would have enhanced the information relating to microstructure and biomechanical parameters since it gives three-dimensional information [39] . The number of hip fractures in the population is not sufficiently high to be able to further subdivide them by type, i.e., trans-cervical or intertrochanteric, which may have provided useful insight into the relationship between specific HSA parameters and fracture. Finally, our findings in elderly, Caucasian women may not be applicable to women of other ethnicities or to men.
Conclusions
This study was performed on the basis of our previous finding that variation in the PTH gene contributed to fracture risk in elderly women, independent of an effect on bone mass; thus, we studied femoral neck bone geometry, a phenotype contributing to bone strength. We conclude that polymorphisms in the PTH gene contribute to differences in femoral neck geometry in elderly women; however, this does not translate into a discriminatory ability between those with and without hip fracture.
